Salven P - Search Results

1

Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6.

Ojala PM, Tiainen M, Salven P, Veikkola T, Castaños-Vélez E, Sarid R, Biberfeld P, Mäkelä TP. Ojala PM, et al. Among authors: salven p. Cancer Res. 1999 Oct 1;59(19):4984-9. Cancer Res. 1999. PMID: 10519412

2

Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.

Jussila L, Valtola R, Partanen TA, Salven P, Heikkilä P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. Jussila L, et al. Among authors: salven p. Cancer Res. 1998 Apr 15;58(8):1599-604. Cancer Res. 1998. PMID: 9563467

3

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.

Salven P, Orpana A, Joensuu H. Salven P, et al. Clin Cancer Res. 1999 Mar;5(3):487-91. Clin Cancer Res. 1999. PMID: 10100697

4

Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.

He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, Salven P, Alitalo K. He Y, et al. Among authors: salven p. Cancer Res. 2004 Jun 1;64(11):3737-40. doi: 10.1158/0008-5472.CAN-04-0088. Cancer Res. 2004. PMID: 15172976

5

Serum VEGF levels in women with a benign breast tumor or breast cancer.

Salven P, Perhoniemi V, Tykkä H, Mäenpää H, Joensuu H. Salven P, et al. Breast Cancer Res Treat. 1999 Jan;53(2):161-6. doi: 10.1023/a:1006178517505. Breast Cancer Res Treat. 1999. PMID: 10326793

6

Enhanced expression of vascular endothelial growth factor in metastatic melanoma.

Salven P, Heikkilä P, Joensuu H. Salven P, et al. Br J Cancer. 1997;76(7):930-4. doi: 10.1038/bjc.1997.486. Br J Cancer. 1997. PMID: 9328154 Free PMC article.

7

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer.

Salven P, Ruotsalainen T, Mattson K, Joensuu H. Salven P, et al. Int J Cancer. 1998 Apr 17;79(2):144-6. doi: 10.1002/(sici)1097-0215(19980417)79:2<144::aid-ijc8>3.0.co;2-t. Int J Cancer. 1998. PMID: 9583728 Clinical Trial.

8

Serum vascular endothelial growth factor is often elevated in disseminated cancer.

Salven P, Mänpää H, Orpana A, Alitalo K, Joensuu H. Salven P, et al. Clin Cancer Res. 1997 May;3(5):647-51. Clin Cancer Res. 1997. PMID: 9815732

9

Interferon alpha-2a therapy in 18 hemangioblastomas.

Niemelä M, Mäenpää H, Salven P, Summanen P, Poussa K, Laatikainen L, Jääskeläinen J, Joensuu H. Niemelä M, et al. Among authors: salven p. Clin Cancer Res. 2001 Mar;7(3):510-6. Clin Cancer Res. 2001. PMID: 11297241

10

High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.

Ruotsalainen T, Joensuu H, Mattson K, Salven P. Ruotsalainen T, et al. Among authors: salven p. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1492-5. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433733 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters